BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36930972)

  • 1. Intestinal Failure-Associated Liver Disease and Growth Pre- and Post-Transition to a Composite Lipid Emulsion.
    Hudson AS; Tyminski N; Turner JM; Silverman JA
    J Pediatr Gastroenterol Nutr; 2023 Jun; 76(6):830-836. PubMed ID: 36930972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and development of cholestasis in surgical neonates receiving an intravenous mixed-oil lipid emulsion.
    Yu LJ; Anez-Bustillos L; Mitchell PD; Ko VH; Secor JD; Hurley AP; Dao DT; Fligor SC; Cho BS; Tsikis ST; Gura KM; Puder M
    JPEN J Parenter Enteral Nutr; 2023 Jan; 47(1):30-40. PubMed ID: 36308408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid strategies to prevent intestinal failure-associated liver disease in neonates: A pilot trial.
    Huff KA; Cruse W; Vanderpool C
    JPEN J Parenter Enteral Nutr; 2023 May; 47(4):482-493. PubMed ID: 36772964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed Oil-Based Lipid Emulsions vs Soybean Oil-Based Lipid Emulsions on Incidence and Severity of Intestinal Failure-Associated Liver Disease in a Neonatal Intensive Care Unit.
    Ferguson CL; Perry C; Subramanian M; Gillette C; Ayers K; Welch C
    JPEN J Parenter Enteral Nutr; 2021 Feb; 45(2):303-308. PubMed ID: 32270888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcomes in Children With Intestinal Failure-Associated Liver Disease Treated With 6 Months of Intravenous Fish Oil Followed by Resumption of Intravenous Soybean Oil.
    Wang C; Venick RS; Shew SB; Dunn JCY; Reyen L; Gou R; Calkins KL
    JPEN J Parenter Enteral Nutr; 2019 Aug; 43(6):708-716. PubMed ID: 30411372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the long-term risk factors associated with intestinal failure-associated liver disease in pediatric and adult patients: The role of lipid injectable emulsions in the development of liver disease.
    Melendez M; Yeh DD
    Nutr Clin Pract; 2022 Oct; 37(5):1142-1151. PubMed ID: 35148446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury.
    Puder M; Valim C; Meisel JA; Le HD; de Meijer VE; Robinson EM; Zhou J; Duggan C; Gura KM
    Ann Surg; 2009 Sep; 250(3):395-402. PubMed ID: 19661785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Fish Oil Lipid Emulsion Use in Children With Intestinal Failure-Associated Liver Disease [Formula: see text].
    Nandivada P; Fell GL; Mitchell PD; Potemkin AK; O'Loughlin AA; Gura KM; Puder M
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):930-937. PubMed ID: 26962059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
    Angsten G; Finkel Y; Lucas S; Kassa AM; Paulsson M; Lilja HE
    JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Complications Associated with Parenteral Nutrition in Preterm Infants < 32 Weeks with a Mixed Oil Lipid Emulsion vs a Soybean Oil Lipid Emulsion in a Level IV Neonatal Intensive Care Unit.
    Franco S; Goriacko P; Rosen O; Morgan-Joseph T
    JPEN J Parenter Enteral Nutr; 2021 Aug; 45(6):1204-1212. PubMed ID: 32862507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid emulsions for parenterally fed preterm infants.
    Kapoor V; Malviya MN; Soll R
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD013163. PubMed ID: 31158919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing the Progression of Intestinal Failure-Associated Liver Disease in Infants Using a Composite Lipid Emulsion: A Pilot Randomized Controlled Trial of SMOFlipid.
    Diamond IR; Grant RC; Pencharz PB; de Silva N; Feldman BM; Fitzgerald P; Sigalet D; Dicken B; Turner J; Marchand V; Ling SC; Moore AM; Avitzur Y; Wales PW
    JPEN J Parenter Enteral Nutr; 2017 Jul; 41(5):866-877. PubMed ID: 26838529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soybean-Oil Lipid Minimization for Prevention of Intestinal Failure-Associated Liver Disease in Late-Preterm and Term Infants With Gastrointestinal Surgical Disorders.
    Gupta K; Wang H; Amin SB
    JPEN J Parenter Enteral Nutr; 2021 Aug; 45(6):1239-1248. PubMed ID: 32854150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Intravenous Soybean and Fish Oil Emulsions in Pediatric Intestinal Failure-Associated Liver Disease: A Multicenter Integrated Analysis Report on Extrahepatic Adverse Events.
    Gura KM; Calkins KL; Premkumar MH; Puder M
    J Pediatr; 2022 Feb; 241():173-180.e1. PubMed ID: 34695449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of Intestinal Failure-Associated Liver Disease by Switching From a Combination Lipid Emulsion Containing Fish Oil to Fish Oil Monotherapy.
    Lee S; Park HJ; Yoon J; Hong SH; Oh CY; Lee SK; Seo JM
    JPEN J Parenter Enteral Nutr; 2016 Mar; 40(3):437-40. PubMed ID: 25560679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composite Lipid Emulsion for the Infant at Risk of Intestinal Failure-associated Liver Disease: The Canadian Perspective.
    Silverman JA; Turner JM; Wales PW
    J Pediatr Gastroenterol Nutr; 2020 Sep; 71(3):283-287. PubMed ID: 32459744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind randomised controlled trial of fish oil-based versus soy-based lipid preparations in the treatment of infants with parenteral nutrition-associated cholestasis.
    Lam HS; Tam YH; Poon TC; Cheung HM; Yu X; Chan BP; Lee KH; Lee BS; Ng PC
    Neonatology; 2014; 105(4):290-6. PubMed ID: 24576844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two formulations of intravenous lipid emulsions in pediatric intestinal failure.
    Naik M; Lawrence A; Davidson A; Chapman J; Ferguson D; Speer AL; Imseis E
    Pediatr Surg Int; 2024 Apr; 40(1):97. PubMed ID: 38581576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal failure-associated liver disease in surgical infants requiring long-term parenteral nutrition.
    Bishay M; Pichler J; Horn V; Macdonald S; Ellmer M; Eaton S; Hill S; Pierro A
    J Pediatr Surg; 2012 Feb; 47(2):359-62. PubMed ID: 22325390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current practices in lipid emulsion utilization in the prevention and treatment of intestinal failure-associated liver disease: A survey of pediatric intestinal rehabilitation and transplant centers.
    Raghu VK; Sevilla WMA; King DE; Alissa F; Rothenberger S; Smith KJ; Horslen SP; Rudolph JA
    JPEN J Parenter Enteral Nutr; 2022 Sep; 46(7):1585-1592. PubMed ID: 35616293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.